Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients
EARLY-VENT
1 other identifier
interventional
1,600
1 country
1
Brief Summary
EARLY-VENT is a multicenter, open-label, three-period cluster-randomized crossover trial designed to evaluate whether early transition from controlled to assisted ventilation improves outcomes in critically ill patients. The study will enroll approximately 1,600 adult patients across 10 ICUs who are expected to require mechanical ventilation for at least 48 hours and meet specific stability criteria (e.g., hemodynamically stable, light sedation). Participating centers will alternate between an experimental strategy, where patients transition to an assisted mode (preferably Pressure Support Ventilation) within 6 hours of eligibility, and a control strategy based on standard care practices. The primary endpoint is the rate of successful extubation at day 28, aiming to demonstrate that transition from controlled to assisted ventilation can reduce ventilation duration and improve prognosis compared to delayed transition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2026
CompletedFirst Posted
Study publicly available on registry
April 9, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
April 23, 2026
April 1, 2026
4.4 years
March 30, 2026
April 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
the rate of successful extubation at day 28
1. No re-intubation or death occurred for 7 consecutive days after extubation, or the patient survived ICU admission with non-invasive mechanical ventilation within 7 days post-extubation-whichever occurs first. 2. For tracheostomy patients: Successful extubation is defined as achieving spontaneous ventilation through the tracheostomy for seven consecutive days without any form of assisted ventilation, or discharge from the ICU without assisted respiratory support, whichever occurs first.
the rate of successful extubation at day 28
Study Arms (2)
early transition
EXPERIMENTALstandard care
NO INTERVENTIONInterventions
Patients are transitioned from controlled to assisted ventilation (preferably Pressure Support Ventilation) within 6 hours of meeting the eligibility criteria
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Expected ICU stay and mechanical ventilation (MV) ≥ 48 hours.
- Currently receiving controlled ventilation mode
- No neuromuscular blocking agents in use, and sedation level RASS ≥ -3.
- P/F ≥ 150 mmHg.
You may not qualify if:
- Severe end-stage irreversible respiratory, cardiac, or neurologic disease that may lead to long-term/chronic ventilator dependence or inability to wean from MV (e.g., interstitial lung disease/pulmonary fibrosis, cardiomyopathy, valvular disease, severe traumatic brain injury, Guillain-Barré syndrome, amyotrophic lateral sclerosis, multiple sclerosis, high cervical spinal cord injury, or other restrictive diseases).
- Expected death or transfer out of the ICU within 48 hours.
- Hemodynamic instability judged by the treating clinician.
- Pregnancy.
- Currently participating in other clinical studies related to mechanical ventilation.
- Any other condition considered unsuitable for participation by the investigator.
- Written informed consent not obtained.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongda Hospital, School of Medicine, Southeast University
Nanjing, Jiangsu, 210009, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
March 30, 2026
First Posted
April 9, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
April 23, 2026
Record last verified: 2026-04